Decheng Capital
About Us
Team
Portfolio
News
Contact
Leading Life Sciences Investment Firm
Established in 2012
$2 Billion of Capital
Delivering Outstanding Returns
In The News
December 8, 2017
EpiMab Biotherapeutics Wins Fortune China Innovation of the Year
November 13, 2017
Arcus Biosciences Announces $107 Million Series C Financing Led by GV and Initiation of Two Clinical Trials
August 29, 2017
ARMO BioSciences Raises $67 Million in a Series C-1 Financing
May 31, 2017
GRAIL and Cirina Combine to Create Global Company Focused on Early Detection of Cancer
May 8, 2017
Aadi Bioscience Closes $23 Million in Series A Funding
May 3, 2017
Hummingbird Bioscience, a rapidly growing therapeutic antibody discovery company today announced it has closed a venture funding round of an undisclosed amount from Decheng Capital
April 25, 2017
EpimAb Biotherapeutics Raises $25M in Series A Financing From International Consortium to Advance Pipeline of Novel Bispecific Antibodies
April 12, 2017
Nature Biotechnology Features ReadCoor As A 2016 Leading Spinout
April 11, 2017
Bristol-Myers Squibb and Apexigen, Inc. Announce Clinical Collaboration to Evaluate Opdivo (nivolumab) in Combination with APX005M in Advanced Solid Tumors
March 19, 2017
Professor Dennis Lo, Decheng’s Advisor, Received the 2016 Future Science Prize Award
Archive
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
